The update to the Introspect platform aims to help clinical laboratories move toward proactive operations and improved productivity.


Tecan, a provider of laboratory automation and solutions, announced the integration of agentic artificial intelligence (AI) capabilities into its laboratory analytics platform, Introspect. The development uses the NVIDIA BioNeMo Agent Toolkit to allow AI agents to access scientific capabilities directly within the platform.

According to a press release from Tecan, the integration is intended to help laboratories move beyond traditional monitoring and reactive troubleshooting. The technology allows for proactive actions that help prevent issues before they impact performance, quality, or scientific outcomes. Early access to the updated platform is now available for clinical laboratory, pharmaceutical, and biotechnology environments.

Improving Laboratory Productivity

The project comes as part of a collaboration between Tecan and NVIDIA announced in March 2026. The partnership aims to enable laboratories to use data-driven, AI-powered platforms to increase productivity and accelerate discovery.

Rather than identifying problems after they occur, these intelligent agents continuously analyze laboratory data, workflows, and system performance. This process helps uncover hidden patterns that may limit throughput, constrain scalability, or reduce operational efficiency. By converting data into recommended actions, laboratories can accelerate decision-making and optimize resource utilization, according to the company.

“Agentic AI has the potential to reshape how laboratories operate. By combining Tecan’s laboratory expertise with NVIDIA’s BioNeMo Agent Toolkit, we are enabling a new generation of intelligent laboratory solutions that can proactively support scientists, improve productivity, and help accelerate scientific outcomes,” says Mukta Acharya, executive vice president, head of the life sciences business division at Tecan, in a release.

Safety and Future Developments

The companies are also focusing on the development of guardrails for the use of AI in laboratory settings. These safeguards are designed to support transparency, reliability, and controlled automation, helping establish the technology for use in research and operational workflows.

Tecan and NVIDIA plan to continue developing AI-enabled platforms for laboratories, including the use of physical AI to enable next-generation laboratory instrumentation. The collaboration focuses on providing the tools needed for laboratories to achieve faster discoveries and higher productivity levels.

Photo caption: Introspect platform

Photo credit: Tecan